ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,317 | -18.8% | 1,526 | 0.0% | 0.00% | – |
| Q2 2023 | $10,239 | +19590.4% | 1,526 | -74.2% | 0.00% | – |
| Q1 2023 | $52 | +15.6% | 5,926 | 0.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 5,926 | 0.0% | 0.00% | – |
| Q3 2022 | $46,000 | -4.2% | 5,926 | -0.9% | 0.00% | – |
| Q2 2022 | $48,000 | +2300.0% | 5,978 | +3683.5% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 158 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -76.9% | 158 | -57.9% | 0.00% | – |
| Q3 2021 | $13,000 | -90.7% | 375 | -89.0% | 0.00% | -100.0% |
| Q2 2021 | $140,000 | +1.4% | 3,416 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $138,000 | -31.7% | 3,416 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $202,000 | – | 3,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |